Review



decellularized autotissue matrix p® bioprosthesis  (AutoTissue GmbH)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    AutoTissue GmbH decellularized autotissue matrix p® bioprosthesis
    Decellularized Autotissue Matrix P® Bioprosthesis, supplied by AutoTissue GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/decellularized+autotissue+matrix+p+bioprosthesis/matrix+p+plus+valves/pm39324571-341-28-28
    Average 90 stars, based on 1 article reviews
    decellularized autotissue matrix p® bioprosthesis - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: ECM roles and biomechanics in cardiac tissue decellularization.
    Article Snippet: Christ T, Paun AC, Grubitzsch H, Holinski S, Falk V, Dushe S. Longterm results after the Ross procedure with the decellularized AutoTissue Matrix P bioprosthesis used for pulmonary valve replacement.

    Article Title: Pulmonary Valve Replacement: A New Paradigm with Tissue Engineering.
    Article Snippet: Decellularized xenografts results overview Study (y) Type Participants Main results Long-term results after the Ross procedure with the decellularized AutoTissue Matrix P bioprosthesis used for pulmonary valve replacement52 (2018) Clinical study - 492 patients underwent a Ross procedure - Mean age 56.7 § 10.7 y - Mean follow-up 7.7 § 4.3 y - Survival rates at 5, 10, and 12.5 y were 82.8%, 70.4%, and 62.4% respectively - Freedom from pulmonary valve reoperation at 5, 10 and 12.5 y was 76.2%, 58.6%, and 53.4%, respectively - Long-term results showed a high rate of reoperation/reintervention for structural pulmonary valve failure Early and late failure of tissueengineered pulmonary valve conduits used for right ventricular outflow tract reconstruction in patients with congenital heart disease53 (2012) Clinical study - 93 patients - Median age and weight at operation were 20 mo and 10.15 kg - Median follow-up duration of 12 mo - 35.5% of patients experienced conduit failure whereas conduit dysfunction occurred in 29% - 2 y freedom from conduit failure and dysfunction was 60.2% (95% confidence Interval: 50.1-69.6) and 77.4% (95% confidence Interval: 67.9-84.7), respectively - Compared with the other conduit for RVOT reconstruction Matrix P conduits showed a high incidence of failure Formation of multiple conduit aneurysms following Matrix P conduit implantation in a boy with tetralogy of Fallot and pulmonary atresia54 (2014) Case report - 6-y-old boy with ToF and pulmonary atresia - Conduit implanted at the age of 16 mo - 5 y later he developed severe stenosis of the distal conduit anastomosis Adverse results of a decellularized tissue-engineered pulmonary valve in humans assessed with magnetic resonance imaging55 (2013) Clinical Trial - 26 patients - Median age of 12.4 y - 52% required valve replacement due to graft failure after 19 mo of implantation - The high frequency of graft failure can be related to inflammation and fibrosis RVOT, right ventricular outflow tract.

    Article Title: Pulmonary Valve Replacement: A New Paradigm with Tissue Engineering.
    Article Snippet: Christ T, Paun AC, Grubitzsch H, Holinski S, Falk V, Dushe S. Long-term results after the Ross procedure with the decellularized AutoTissue Matrix P bioprosthesis used for pulmonary valve replacement.



    Similar Products

    decellularized autotissue matrix p® bioprosthesis  (AutoTissue GmbH)
    90
    AutoTissue GmbH decellularized autotissue matrix p® bioprosthesis
    Decellularized Autotissue Matrix P® Bioprosthesis, supplied by AutoTissue GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/decellularized+autotissue+matrix+p+bioprosthesis/matrix+p+plus+valves/pm39324571-341-28-28
    Average 90 stars, based on 1 article reviews
    decellularized autotissue matrix p® bioprosthesis - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    decellularized autotissue matrix p bioprosthesis  (AutoTissue GmbH)
    90
    AutoTissue GmbH decellularized autotissue matrix p bioprosthesis
    Decellularized Autotissue Matrix P Bioprosthesis, supplied by AutoTissue GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/decellularized+autotissue+matrix+p+bioprosthesis/matrix+p+plus+valves/pm35460681-275-22-21
    Average 90 stars, based on 1 article reviews
    decellularized autotissue matrix p bioprosthesis - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results